Presented by USVC Get on Amazon

2.6 - Psychedelics

This chapter needs to be handled carefully.

Psychedelics are powerful tools for emotional and psychological work. They're also illegal in most jurisdictions, can be dangerous in the wrong context, and aren't appropriate for everyone. I'm including them in this book because the evidence for their therapeutic potential has become hard to ignore, and pretending they don't exist would leave a meaningful hole in any serious treatment of mental and emotional well-being. But this isn't a how-to guide. It's an orientation.

If you're going to engage with any of what's discussed here, do so legally, do so with proper guidance, and do so with the safety considerations laid out at the end of this chapter.

What psychedelics actually do

The mechanism is, in important ways, similar to what breathwork does (Chapter 2.5): they bypass the talking mind, surface buried emotional material, and allow access to layers of experience that the default state of consciousness keeps suppressed.

What's different is the depth and duration. A breathwork session might give you 90 minutes of access to non-ordinary states. A psilocybin session might give you six to eight hours. An ayahuasca night, ten or more. The doors that open are similar; the size of the room you walk into is different.

Modern research, especially the work coming out of Johns Hopkins (Roland Griffiths and team), Imperial College London (Robin Carhart-Harris), and the studies leading to MDMA-assisted therapy for PTSD, has shown that a small number of guided psychedelic experiences can produce changes in conditions like treatment-resistant depression, addiction, end-of-life anxiety, and PTSD that previously took years of therapy or pharmaceuticals to even partially address, when they were treatable at all.

The main substances

A brief orientation:

Psilocybin (magic mushrooms). The most-studied psychedelic in modern therapeutic research. Sessions typically last 4 to 6 hours, with the most intense effects in the middle 2 to 3. Used in clinical trials for depression, addiction, end-of-life anxiety, and existential distress. Reputation as one of the gentler classic psychedelics, though "gentle" is relative.

Psilocybin is also the only psychedelic I have personal experience with. The single session was about four to five hours long, more intense than I'd expected. My thinking mind went quiet completely. There was a strong, sustained feeling of unity with everything around me, including a clear urge to hug the trees. Vibrations moved through the body. Sensory input was amplified across the board, and I could feel the way energy was traveling through me. At one point I started crying without quite knowing why. At another point I felt as if I were being tickled, and the laughter that followed was uncontrollable. The experience was cathartic but also, somehow, soothing. By the end of the session I felt peaceful, quiet, and rested in a way that's hard to describe.

LSD. Longer than psilocybin (8 to 12 hours), historically more associated with the recreational and visionary side. Also has therapeutic research behind it, though less of the recent academic work has focused on it.

MDMA. Not a classic psychedelic but an "empathogen." Produces feelings of openness, safety, and connection rather than visual distortions. Has been the focus of major clinical trials for PTSD treatment, with results that came very close to FDA approval. Particularly effective in therapeutic settings because it temporarily quiets the fear response, allowing people to revisit traumatic material without being re-traumatized.

Ayahuasca. A plant medicine from the Amazon basin, traditionally prepared as a brew by indigenous shamans. Effects last 4 to 6 hours, often with intense physical purging (the "purge" is considered part of the medicine in traditional contexts). Used in ceremonial settings, often over multiple nights. Legal in some countries, regulated in others.

Set and setting

This is the single most important concept in psychedelic work. Two things determine the quality and outcome of a psychedelic experience at least as much as the substance itself:

A psychedelic experience in a good set and setting can be deeply healing - sometimes the most healing experience of someone's life. The same substance in a bad set and setting can produce lasting psychological harm. The substance itself is a smaller part of the equation than the culture realizes.

This is the central reason psychedelics shouldn't be approached casually, despite their growing cultural acceptance.

Working with guides

For deep therapeutic work, find a trained guide, therapist, or facilitator. This person serves several roles:

Underground psychedelic therapy exists in many places and varies enormously in quality. In places where psychedelic therapy is legal (Oregon's psilocybin program, supervised ketamine clinics in many countries, ayahuasca retreats in Brazil, Peru, and Costa Rica), the legal route is the safer one. In places where it isn't legal, the underground community has trained facilitators, but you have to evaluate them carefully and accept the legal and safety risks of working outside a regulated framework.

Integration

What you do after a psychedelic session is at least as important as the session itself. The experience surfaces material; integration is the work of weaving that material into your ordinary life so the insights actually change something.

This usually involves:

Many people make the mistake of stacking multiple psychedelic experiences too close together, chasing the next breakthrough. The breakthroughs from one good session typically take months to fully integrate. Going too fast often produces less, not more.

Safety and contraindications

Psychedelics aren't for everyone. The serious contraindications include:

If you're considering psychedelic work, take an unhurried, careful look at yourself against these factors first.

Microdosing

A separate practice worth mentioning: microdosing is the use of sub-perceptual doses of a psychedelic (typically psilocybin or LSD) on a regular schedule, with the intention of producing subtle benefits to mood, creativity, focus, and emotional regulation. Doses are small enough that you wouldn't notice acute effects.

The research on microdosing is mixed. Some studies suggest real benefits; others suggest much of what people experience is placebo. Anecdotal reports are widespread and positive, but anecdote isn't evidence. If you're going to try it, run a real comparison to a placebo period and see whether the effects hold up.

Legal status of microdosing follows the legal status of the underlying substance.

The legal landscape is shifting rapidly:

This is changing rapidly. By the time you read this, some of the above will be different. Check current law in your jurisdiction before doing anything.